Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:BDMD NASDAQ:HYPR NASDAQ:NRXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.13$2.09$0.76▼$2.73$80.56M1.4356,687 shs19,303 shsBDMDBaird Medical Investment$2.66+2.3%$2.46$1.05▼$12.50$92.89M-0.97182,660 shs113,081 shsHYPRHyperfine$1.41+1.4%$1.15$0.53▼$1.90$109.23M1.07237,955 shs249,205 shsNRXSNeurAxis$2.43+3.8%$2.51$1.33▼$6.20$23.99M3.1601,650 shs48,148 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+1.43%+3.40%-1.39%+21.02%+83.62%BDMDBaird Medical Investment+6.12%+5.26%+14.04%-63.38%+259,999,900.00%HYPRHyperfine-2.11%+16.81%0.00%+98.49%+33.65%NRXSNeurAxis-3.51%-3.31%-2.90%-7.51%-21.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.13$2.09$0.76▼$2.73$80.56M1.4356,687 shs19,303 shsBDMDBaird Medical Investment$2.66+2.3%$2.46$1.05▼$12.50$92.89M-0.97182,660 shs113,081 shsHYPRHyperfine$1.41+1.4%$1.15$0.53▼$1.90$109.23M1.07237,955 shs249,205 shsNRXSNeurAxis$2.43+3.8%$2.51$1.33▼$6.20$23.99M3.1601,650 shs48,148 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+1.43%+3.40%-1.39%+21.02%+83.62%BDMDBaird Medical Investment+6.12%+5.26%+14.04%-63.38%+259,999,900.00%HYPRHyperfine-2.11%+16.81%0.00%+98.49%+33.65%NRXSNeurAxis-3.51%-3.31%-2.90%-7.51%-21.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 3.00BuyN/AN/ABDMDBaird Medical Investment 0.00N/AN/AN/AHYPRHyperfine 2.67Moderate Buy$1.28-8.98% DownsideNRXSNeurAxis 3.00Buy$7.00188.07% UpsideCurrent Analyst Ratings BreakdownLatest NRXS, HYPR, BDMD, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/15/2025HYPRHyperfineWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$0.68 ➝ $0.858/14/2025HYPRHyperfineLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$1.50 ➝ $2.006/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$7.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$46.51M1.73N/AN/A$0.38 per share5.61BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AHYPRHyperfine$12.89M8.60N/AN/A$0.67 per share2.10NRXSNeurAxis$3.22M7.46N/AN/A($0.27) per share-9.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/7/2025 (Estimated)BDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/AHYPRHyperfine-$40.72M-$0.52N/AN/AN/A-364.54%-84.82%-69.39%11/11/2025 (Estimated)NRXSNeurAxis-$14.63M-$0.99N/A∞N/A-492.76%N/A-641.25%N/ALatest NRXS, HYPR, BDMD, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025HYPRHyperfine-$0.12-$0.12N/A-$0.12$3.00 million$2.70 million8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ABDMDBaird Medical InvestmentN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95BDMDBaird Medical InvestmentN/AN/AN/AHYPRHyperfineN/A5.024.41NRXSNeurAxisN/A0.240.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%BDMDBaird Medical Investment19.78%HYPRHyperfine15.03%NRXSNeurAxis11.77%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%BDMDBaird Medical Investment78.90%HYPRHyperfine30.98%NRXSNeurAxis26.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableBDMDBaird Medical InvestmentN/A35.73 million7.54 millionN/AHYPRHyperfine19078.58 million54.24 millionOptionableNRXSNeurAxis199.87 million6.09 millionNot OptionableNRXS, HYPR, BDMD, and APYX HeadlinesRecent News About These CompaniesNeurAxis (NASDAQ:NRXS) Stock Price Down 3.3% - Time to Sell?September 16 at 3:44 AM | americanbankingnews.comNeurAxis Enters Market Offering Agreement with Craig-HallumSeptember 2, 2025 | tipranks.comNeurAxis Stock Down Following Q2 Earnings Despite Revenue GrowthAugust 18, 2025 | zacks.comNeurAxis, Inc. Reports Robust Q2 2025 GrowthAugust 13, 2025 | msn.comNeuraxis reports Q2 EPS (22c) vs. (42c) last yearAugust 12, 2025 | msn.comNeurAxis, Inc. (NRXS) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comEarnings Outlook For NeuraxisAugust 11, 2025 | benzinga.comNeuraxis ends Masimo license agreement and launches employee stock planJuly 5, 2025 | investing.comNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Acquires $800,001.00 in StockJuly 4, 2025 | insidertrades.comNeurAxis, Inc. Ends Agreement with Masimo CorporationJuly 3, 2025 | tipranks.comNeurAxis, Inc. (NRXS) Latest Stock News & Headlines - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comThe Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxisJune 27, 2025 | sharewise.comSNeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal PainJune 17, 2025 | quiverquant.comQNeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered LivesJune 17, 2025 | globenewswire.comNeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBSJune 10, 2025 | finance.yahoo.comNeurAxis, Inc. Announces Inclusion of PENFS Technology in Pediatric Gastroenterology Guidelines for Functional Abdominal Pain TreatmentJune 10, 2025 | quiverquant.comQNeurAxis, Inc. Approves Key Proposals at Annual MeetingJune 4, 2025 | tipranks.comNeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim TherapyMay 22, 2025 | quiverquant.comQNeurAxis Announces Closing of $5.0 Million Registered Direct OfferingMay 22, 2025 | globenewswire.comNeurAxis, Inc. Announces $5 Million Stock OfferingMay 22, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNRXS, HYPR, BDMD, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$2.13 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.16 +0.03 (+1.60%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Baird Medical Investment NASDAQ:BDMD$2.66 +0.06 (+2.31%) As of 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Hyperfine NASDAQ:HYPR$1.41 +0.02 (+1.44%) Closing price 04:00 PM EasternExtended Trading$1.42 +0.01 (+0.35%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.NeurAxis NASDAQ:NRXS$2.43 +0.09 (+3.85%) Closing price 03:59 PM EasternExtended Trading$2.37 -0.06 (-2.30%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
